Ausgabe 1/2014
Inhalt (21 Artikel)
Reproductive risk factors and breast cancer subtypes: a review of the literature
Kristin N. Anderson, Richard B. Schwab, Maria Elena Martinez
Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight
Suzanne A. W. Fuqua, Guowei Gu, Yassine Rechoum
Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review
Hanne Verbelen, Nick Gebruers, Fau-Mei Eeckhout, Kim Verlinden, Wiebren Tjalma
Andrographolide prevents human breast cancer-induced osteoclastic bone loss via attenuated RANKL signaling
Zanjing Zhai, Xinhua Qu, Wei Yan, Haowei Li, Guangwang Liu, Xuqiang Liu, Tingting Tang, An Qin, Kerong Dai
Diallyl trisulfide inhibits estrogen receptor-α activity in human breast cancer cells
Eun-Ryeong Hahm, Shivendra V. Singh
α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma
Masaoki Ito, Man Hagiyama, Takahiro Mimae, Takao Inoue, Takashi Kato, Azusa Yoneshige, Jun Nakanishi, Tadashi Kondo, Morihito Okada, Akihiko Ito
Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients
Cynthia L. Miller, Michelle C. Specht, Melissa N. Skolny, Nora Horick, Lauren S. Jammallo, Jean O’Toole, Mina N. Shenouda, Betro T. Sadek, Barbara L. Smith, Alphonse G. Taghian
A combination treatment with DNA methyltransferase inhibitors and suramin decreases invasiveness of breast cancer cells
Sahra Borges, Heike R. Döppler, Peter Storz
Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models
John Do, Deshka Foster, Corinne Renier, Hannes Vogel, Sahar Rosenblum, Timothy C. Doyle, Victor Tse, Irene Wapnir
Mammographic screening detects low-risk tumor biology breast cancers
C. A. Drukker, M. K. Schmidt, E. J. T. Rutgers, F. Cardoso, K. Kerlikowske, L. J. Esserman, F. E. van Leeuwen, R. M. Pijnappel, L. Slaets, J. Bogaerts, L. J. van’t Veer
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”
Chiara Foroni, Manuela Milan, Carla Strina, Mariarosa Cappelletti, Claudia Fumarola, Mara Bonelli, Ramona Bertoni, Giuseppina Ferrero, Mara Maldotti, Elena Takano, Daniele Andreis, Sergio Venturini, Giulia Brugnoli, Pier Giorgio Petronini, Vanessa Zanoni, Laura Pritzker, Kenneth Pritzker, Amadeo Parissenti, Daniele Santini, Stephen B. Fox, Alberto Bottini, Daniele Generali
Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer
Dorit Pud, Gil Har-Zahav, Yael Laitman, Tami Rubinek, Adva Yeheskel, Sarah Ben-Ami, Bella Kaufman, Eitan Friedman, Zvi Symon, Ido Wolf
Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status
Martin P. Nilsson, Linda Hartman, Ingrid Idvall, Ulf Kristoffersson, Oskar T. Johannsson, Niklas Loman
Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients
A. L. Wong, K. Y. Seng, E. M. Ong, L. Z. Wang, H. Oscar, M. T. Cordero, R. Copones, L. Fan, S. H. Tan, B. C. Goh, S. C. Lee
Response and prognosis after neoadjuvant chemotherapy in 1,051 patients with infiltrating lobular breast carcinoma
Sibylle Loibl, Cristina Volz, Christine Mau, Jens-Uwe Blohmer, Serban D. Costa, Holger Eidtmann, Peter A. Fasching, Bernd Gerber, Claus Hanusch, Christian Jackisch, Sherko Kümmel, Jens Huober, Carsten Denkert, Jörn Hilfrich, Gottfried E. Konecny, Werner Fett, Elmar Stickeler, Nadia Harbeck, Keyur M. Mehta, Valentina Nekljudova, Gunter von Minckwitz, Michael Untch
Risk of cardiovascular adverse events from trastuzumab (Herceptin®) in elderly persons with breast cancer: a population-based study
H.-T. Tsai, C. Isaacs, A. Z. Fu, J. L. Warren, A. N. Freedman, A. Barac, C.-Y. Huang, A. L. Potosky
Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1
J. G. Dowty, E. Lee, R. McKean-Cowdin, B. E. Henderson, L. Bernstein, G. Ursin, J. L. Hopper
Providers of follow-up care in a population-based sample of breast cancer survivors
Christopher R. Friese, Kathryn A. Martinez, Paul Abrahamse, Ann S. Hamilton, John J. Graff, Reshma Jagsi, Jennifer J. Griggs, Sarah T. Hawley, Steven J. Katz
Effect of multiplicity, laterality, and age at onset of breast cancer on familial risk of breast cancer: a nationwide prospective cohort study
Elham Kharazmi, Tianhui Chen, Steven Narod, Kristina Sundquist, Kari Hemminki
Analyzing factors associated with women’s attitudes and behaviors toward screening mammography using design-based logistic regression
Mahboubeh Madadi, Shengfan Zhang, Karen H. Kim Yeary, Louise M. Henderson
Sclerosing adenosis and risk of breast cancer
Daniel W. Visscher, Aziza Nassar, Amy C. Degnim, Marlene H. Frost, Robert A. Vierkant, Ryan D. Frank, Yaman Tarabishy, Derek C. Radisky, Lynn C. Hartmann